---
title: "GENZYME THERAPEUTICS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/36fc62e2-42fe-50db-ad5d-a37ac50022fe
json: https://whiteintel.dev/api/public/dossier/36fc62e2-42fe-50db-ad5d-a37ac50022fe
identifier: oo:GB-COH-04316333
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GENZYME THERAPEUTICS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-04316333`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/36fc62e2-42fe-50db-ad5d-a37ac50022fe  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/36fc62e2-42fe-50db-ad5d-a37ac50022fe  

## Cross-source identity

The same real-world entity, resolved across sources:

- **GENZYME THERAPEUTICS LIMITED** — GLEIF · `lei:54930070ZX7ZM2WSJU92` — https://whiteintel.dev/entity/a392d260-80ab-5d99-9279-e7f67f556d0d

## Ownership & control

### Owners / controllers

- **AVENTIS PHARMA LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/26b300cb-b438-543f-aba7-0b4a6d47ca89
- **SANOFI-AVENTIS UK HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/daca43db-027f-56c7-9c64-c224fd79f934
- **AVENTIS PHARMA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/26b300cb-b438-543f-aba7-0b4a6d47ca89

### UBO chain (walk to the ultimate owner)

A **20-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `04316333`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2001-11-05
- **Registered office:** 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, England
- **SIC:** 74990

### Officers

- MOHAMED, Walaa Mostafa Abbas Awad — director · Egyptian · appointed 2026-02-01
- MOUSSA, Ahmed Mohamed Moustafa — director · Egyptian · appointed 2026-02-01
- BECKER, Marc — secretary · Usa · appointed 2006-05-26 · resigned 2008-07-02
- DENNIS, Jonathan Charles — secretary · British · appointed 2008-07-02 · resigned 2009-02-23
- DROHAN, Paul Victor — secretary · Canadian · appointed 2005-11-04 · resigned 2006-05-26
- FRANKLIN, Andrew Timothy — secretary · appointed 2011-06-01 · resigned 2012-12-31
- FRENCH, David Allen — secretary · British · appointed 2009-02-23 · resigned 2009-10-23
- HARROW, Terence Alfred, Dr — secretary · British · appointed 2003-11-04 · resigned 2005-11-04
- KEANE, Antoinette — secretary · appointed 2013-01-24 · resigned 2016-09-07
- SHORT, John Richard — secretary · British · appointed 2001-11-05 · resigned 2003-11-04
- SMITH, Suzanne Elaine — secretary · British · appointed 2009-10-23 · resigned 2011-04-30
- BAIRD, Jessamy Rachel — director · British · appointed 2022-10-01 · resigned 2024-03-01
- COUSINS, Simon John, Dr — director · British · appointed 2003-11-04 · resigned 2005-11-04
- DENNIS, Jonathan Charles — director · British · appointed 2008-07-02 · resigned 2009-02-23
- DROHAN, Paul Victor — director · Canadian · appointed 2005-11-04 · resigned 2012-10-31
- DUHALDE, Francois-Xavier — director · French · appointed 2016-04-01 · resigned 2021-03-31
- FARMER, Nicole Suzanne — director · British · appointed 2020-05-16 · resigned 2022-10-01
- FRANKLIN, Andrew Timothy — director · British · appointed 2010-08-10 · resigned 2012-12-31
- FULLER, David, Dr — director · British · appointed 2006-02-24 · resigned 2007-09-04
- GOLDER, Quentin Robert — director · British · appointed 2001-11-05 · resigned 2003-11-04

### Beneficial owners (Persons with Significant Control)

- [Aventis Pharma Limited](https://whiteintel.dev/entity/26b300cb-b438-543f-aba7-0b4a6d47ca89) — 75–100% shares · corporate PSC · England — since 2019-04-30
- [Sanofi-Aventis Uk Holdings Limited](https://whiteintel.dev/entity/daca43db-027f-56c7-9c64-c224fd79f934) — 75–100% shares · corporate PSC · United Kingdom — ceased 2019-04-30

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/04316333
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/04316333

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **GENZYME THERAPEUTICS LIMITED** — https://whiteintel.dev/entity/36fc62e2-42fe-50db-ad5d-a37ac50022fe · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GENZYME THERAPEUTICS LIMITED**. Human view: https://whiteintel.dev/entity/36fc62e2-42fe-50db-ad5d-a37ac50022fe · Structured JSON: https://whiteintel.dev/api/public/dossier/36fc62e2-42fe-50db-ad5d-a37ac50022fe._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._